Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study

Figure 2

Epidemiological curve of included cases by exposure. Cases who were exposed (black), or assumed to be exposed (dark grey), and those whose vaccination was assumed to have taken place within 7 days before symptom onset (assumed unexposed; light grey) or who were unexposed (white) are presented by day of symptom onset. The assumption on exposure was based on cases with known date of vaccination. * For 1 patient, day of symptom onset was unknown. For this patient we used 1 day before day of admission as day of symptom onset for this epidemic curve.

Back to article page